Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2016	FY 2015
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2016	Dec 31, 2015
Pharmaceutical Industry	2.01B	2.36B	2.07B	1.45B	3.94B
Pharmaceutical Industry Growth	-14.68%	13.66%	43.23%	-63.22%	2.17%
Pharmaceutical Commercial	203.56M	257.93M	255.06M	2.02B	2.43B
Pharmaceutical Commercial Growth	-21.08%	1.13%	-87.39%	-16.89%	12.76%
Unallocated Other Business	59.09M	32.70M	35.27M	117.61M	108.29M
Unallocated Other Business Growth	80.72%	-7.31%	-70.01%	8.60%	26.76%
Total	2.27B	2.65B	2.36B	3.59B	6.48B
Total Growth	-14.12%	11.99%	-34.11%	-44.62%	6.26%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2016	FY 2015
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2016	Dec 31, 2015
East China	922.29M	1.08B	948.50M	2.25B	3.82B
East China Growth	-14.30%	13.46%	-57.82%	-41.10%	14.91%
Central China	197.33M	271.99M	202.80M	213.88M	503.35M
Central China Growth	-27.45%	34.11%	-5.18%	-57.51%	-8.04%
North China	294.07M	323.57M	210.65M	160.22M	539.31M
North China Growth	-9.12%	53.60%	31.48%	-70.29%	3.05%
Southern China	168.73M	210.98M	205.93M	187.17M	415.68M
Southern China Growth	-20.03%	2.45%	10.03%	-54.97%	1.65%
Southwest Region	242.10M	279.12M	278.81M	288.87M	350.97M
Southwest Region Growth	-13.26%	0.11%	-3.48%	-17.69%	-14.06%
Northeast China Region	212.46M	269.49M	307.62M	210.33M	441.17M
Northeast China Region Growth	-21.16%	-12.39%	46.25%	-52.32%	5.11%
Northwestern Region	124.16M	141.35M	141.17M	149.51M	269.49M
Northwestern Region Growth	-12.16%	0.13%	-5.58%	-44.52%	-23.17%
Other Areas	53.24M	42.01M	33.10M	11.37M	31.87M
Other Areas Growth	26.74%	26.91%	191.14%	-64.32%	7.04%
Unallocated	59.09M	32.70M	35.27M	117.61M	108.29M
Unallocated Growth	80.72%	-7.31%	-70.01%	8.60%	26.76%
Total	2.27B	2.65B	2.36B	3.59B	6.48B
Total Growth	-14.12%	11.99%	-34.11%	-44.62%	6.26%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 1, 2026

Data Sources Report a data error